DRW8 Draegerwerk AG

EQS-News: Drägerwerk AG & Co. KGaA: Dräger makes sustainability and quality an Executive Board responsibility

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Personnel/Sustainability
Drägerwerk AG & Co. KGaA: Dräger makes sustainability and quality an Executive Board responsibility

08.05.2024 / 16:45 CET/CEST
The issuer is solely responsible for the content of this announcement.


Dräger makes sustainability and quality an Executive Board responsibility

Stefanie Hirsch will be appointed to the Executive Board as of July 1, 2024

Dräger is creating a new, additional Executive Board position for sustainability and quality. At its meeting today, the Supervisory Board of Drägerwerk Verwaltungs AG decided to appoint Stefanie Hirsch to the Executive Board as Chief Sustainability and Quality Officer as of July 1, 2024. 

"Sustainability has always been deeply rooted in Dräger's corporate culture and is becoming increasingly important for the future. It is a cross-cutting topic and affects all processes and areas of our company. The same applies to quality, one of our four strengths and a cornerstone of our company. I am delighted to have Stefanie Hirsch as an experienced and committed colleague on the Executive Board." - Stefan Dräger, CEO of Drägerwerk Verwaltungs AG.

Stefanie Hirsch was born in Worms, Germany in 1975 and studied biotechnology at Mannheim University of Applied Sciences. She began her professional career at Abbott Diagnostics in the Research & Development department. This was followed by various management positions in the areas of Operations, Quality and Regulatory Affairs, including abroad. She has also worked at Ortho-Clinical Diagnostics, a global provider of products and services for transfusion services and clinical laboratories, where she led the quality management and regulatory affairs teams in the company's international sales & service offices in the EMEA and Asia regions.

Hirsch has been with Dräger since 2018 and is Head of Quality and Regulatory Affairs in Medical Technology. She has also been Head of Corporate Quality & Regulatory Affairs, including Global Environmental Health and Safety Management, since 2020.

Image material:

fncls.ssp?fn=download2_file&code_str=aaea7a5e448e7efd32de8b92d16508bb

Photo: Stefanie Hirsch will be appointed to the Executive Board of Drägerwerk Verwaltungs AG as of July 1, 2024. © Drägerwerk AG & Co. KGaA

Dräger. Technology for Life®
Dräger is an international leader in the fields of medical and safety technology. Our products protect, support, and save lives. Founded in 1889, Dräger generated revenues of around € 3,4 billion in 2023. The Dräger Group is currently present in over 190 countries and has more than 16,000 employees worldwide. For more information, visit .

 



08.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck
Germany
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
E-mail:
Internet:
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555071 Genussschein D
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Stuttgart, Tradegate Exchange
EQS News ID: 1899015

 
End of News EQS News Service

1899015  08.05.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1899015&application_name=news&site_id=research_pool
EN
08/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Draegerwerk AG

 PRESS RELEASE

EQS-News: Drägerwerk AG & Co. KGaA: Dräger steigert im Geschäftsjahr 2...

EQS-News: Drägerwerk AG & Co. KGaA / Schlagwort(e): Jahresbericht/Dividende Drägerwerk AG & Co. KGaA: Dräger steigert im Geschäftsjahr 2024 den Gewinn und erhöht die Dividende 31.03.2025 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Dräger steigert im Geschäftsjahr 2024 den Gewinn und erhöht die Dividende Auftragseingang übertrifft hohes Vorjahresniveau Umsatz erreicht annähernd starken Vorjahreswert EBIT rund 17 Prozent im Plus Gute Geschäftsentwicklung im vierten Quartal Höhere Dividende für 2024: 1,97 Euro je Stamma...

 PRESS RELEASE

EQS-News: Drägerwerk AG & Co. KGaA: Dräger increases net profit in fis...

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Annual Report/Dividend Drägerwerk AG & Co. KGaA: Dräger increases net profit in fiscal year 2024 and raises dividend 31.03.2025 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Dräger increases net profit in fiscal year 2024 and raises dividend Order intake exceeds high prior-year level Net sales close to strong prior-year figure EBIT up around 17 percent Good business performance in the fourth quarter Higher dividend for 2024: EUR 1.97 per common share (2023: EUR 1.74) and EUR 2...

 PRESS RELEASE

EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1...

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Miscellaneous Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice 22.01.2025 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice The share buyback of Drägerwerk AG & Co. KGaA (“Dräger”), which had begun on October 7, 2024, was completed on January 20, 2025. A total of 77,316 prefe...

 PRESS RELEASE

EQS-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 ...

EQS-News: Drägerwerk AG & Co. KGaA / Schlagwort(e): Sonstiges Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener Aktien – Abschlussmeldung 22.01.2025 / 14:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener Aktien – Abschlussmeldung Der am 7. Oktober 2024 begonnene Aktienrückkauf der Drägerwerk AG & Co. KGaA („Dräger“) ist am 20. Januar 2025 abgeschlossen worden. In diesem Z...

 PRESS RELEASE

EQS-News: Drägerwerk AG & Co. KGaA: Changes in the chair of the Dräger...

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Personnel Drägerwerk AG & Co. KGaA: Changes in the chair of the Dräger Supervisory Board 11.12.2024 / 14:06 CET/CEST The issuer is solely responsible for the content of this announcement. Changes in the chair of the Dräger Supervisory Board Lübeck – Stefan Lauer, currently Chairman of all Dräger Supervisory Boards, has decided to step down as Chairman at the end of the year for health reasons. The Supervisory Board committees approved this move at their meetings today and passed the following resolutions: From January 1,...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch